Brain Scanner Detects Cannabis Impairment Far More Accurately Than Field Sobriety Tests
A portable brain imaging device (fNIRS) detected THC impairment with 90% accuracy and only 5% false positives — dramatically outperforming field sobriety tests which had 34% false positive rates.
Quick Facts
What This Study Found
Resting-state fNIRS achieved ROC-AUC=0.87, accuracy=0.90, and false-positive rate=0.05 for THC impairment detection vs. FST ROC-AUC=0.75, accuracy=0.69, and false-positive rate=0.34 — all differences statistically significant (p<.005).
Key Numbers
183 participants; fNIRS: AUC=0.87, accuracy=0.90, FPR=0.05; FST: AUC=0.75, accuracy=0.69, FPR=0.34; precision difference=0.23 (p<.001); accuracy difference=0.15 (p<.001); FPR difference=-0.25 (p<.001).
How They Did This
Double-blind, randomized, crossover trial of 183 cannabis users receiving oral synthetic THC (5-80mg) or placebo, with fNIRS brain scans and field sobriety tests at baseline, 100min, and 200min post-dose, analyzed with machine learning classifiers.
Why This Research Matters
Current THC impairment detection relies on biased subjective tests — a portable, objective brain imaging approach could revolutionize cannabis impairment testing for law enforcement and workplace safety.
The Bigger Picture
The 34% false positive rate of field sobriety tests means 1 in 3 unimpaired people could be wrongly identified as impaired — fNIRS reduces this to 1 in 20, with enormous implications for criminal justice fairness.
What This Study Doesn't Tell Us
Laboratory setting with synthetic THC pills differs from real-world cannabis smoking; single-site study; fNIRS hardware still needs miniaturization for field use; trained on regular cannabis users.
Questions This Raises
- ?Can fNIRS devices be made portable enough for roadside use?
- ?Will the classifier work for occasional users or different consumption methods?
- ?How will courts handle neural impairment evidence?
Trust & Context
- Key Stat:
- Evidence Grade:
- Rigorous double-blind randomized crossover design published in JAMA Network Open with large sample and machine learning validation, though laboratory setting limits real-world generalizability.
- Study Age:
- Published in 2026 in JAMA Network Open, representing a major advance in objective cannabis impairment detection technology.
- Original Title:
- Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial.
- Published In:
- JAMA network open, 9(1), e2556647 (2026)
- Authors:
- Berchansky, Moshe, Evins, A Eden(14), Evohr, Bryn(3), Himmelsbach, Zachary, Pachas, Gladys N, Karunakaran, Keerthana Deepti, Laufer Goldshtein, Bracha, Ozana, Nisan, Gilman, Jodi M
- Database ID:
- RTHC-08116
Evidence Hierarchy
Frequently Asked Questions
Can a brain scanner tell if someone is impaired by cannabis?
Yes — this study showed a portable brain imaging device (fNIRS) detected THC impairment with 90% accuracy by measuring prefrontal cortex activation patterns, outperforming traditional field sobriety tests.
Why are field sobriety tests bad for detecting cannabis impairment?
Field sobriety tests had a 34% false positive rate — meaning 1 in 3 unimpaired people could be wrongly flagged — and only 69% overall accuracy. They were designed for alcohol, not cannabis.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-08116APA
Berchansky, Moshe; Evins, A Eden; Evohr, Bryn; Himmelsbach, Zachary; Pachas, Gladys N; Karunakaran, Keerthana Deepti; Laufer Goldshtein, Bracha; Ozana, Nisan; Gilman, Jodi M. (2026). Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial.. JAMA network open, 9(1), e2556647. https://doi.org/10.1001/jamanetworkopen.2025.56647
MLA
Berchansky, Moshe, et al. "Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial.." JAMA network open, 2026. https://doi.org/10.1001/jamanetworkopen.2025.56647
RethinkTHC
RethinkTHC Research Database. "Detection of Δ9-Tetrahydrocannabinol Impairment Using Restin..." RTHC-08116. Retrieved from https://rethinkthc.com/research/berchansky-2026-detection-of-9tetrahydrocannabinol-impairment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.